Europe Dry Eye Syndrome Treatment Market Size & Outlook
Europe dry eye syndrome treatment market, 2018-2030 (US$M)
Related Markets
Europe dry eye syndrome treatment market highlights
- The Europe dry eye syndrome treatment market generated a revenue of USD 1,923.9 million in 2024.
- The market is expected to grow at a CAGR of 6.4% from 2025 to 2030.
- In terms of segment, evaporative dry eye syndrome was the largest revenue generating type in 2024.
- Evaporative Dry Eye Syndrome is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 1,923.9 million |
| Market revenue in 2030 | USD 2,787.3 million |
| Growth rate | 6.4% (CAGR from 2025 to 2030) |
| Largest segment | Evaporative dry eye syndrome |
| Fastest growing segment | Evaporative Dry Eye Syndrome |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
| Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
Other key industry trends
- In terms of revenue, Europe region accounted for 30.6% of the global dry eye syndrome treatment market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,826.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dry Eye Syndrome Treatment Market Scope
Dry Eye Syndrome Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe dry eye syndrome treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.63% in 2024. Horizon Databook has segmented the Europe dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the market in the region can be attributed to an increase in research funding and the local presence of key market players in this region. The number of biopharmaceutical companies is growing in Europe, owing to increasing investments. For instance, in 2021, EIT Health, an EU-funded program initiated to improve health, chose two innovation teams to get additional support over the next 2 years: Perivision from Switzerland and INVENTION from Sweden.
The teams have received up to USD 1.70 million (EUR 1.5 million) in investment to provide novel, effective, and safe technology to Europeans with debilitating eye and visual disorders in the region. Moreover, the population in Europe is rapidly aging. According to the UN, people aged over 65 constitute 19% of the population, which accounts for about 183 million. This population is at a relatively high risk of dry eye diseases.
According to the European Ophthalmic Review, the prevalence of dry eye disease in Europe ranges from 7% to 22%. With a rapidly aging population and people becoming increasingly reliant on multiscreen devices, the burden of dry eye disease is anticipated to increase in the future. It is a chronic condition that can interfere with daily activities and lead to contact lens intolerance, may also have a negative impact on refractive surgery outcomes, and be linked to post-ocular surgery problems.
Reasons to subscribe to Europe dry eye syndrome treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe dry eye syndrome treatment market databook
-
Our clientele includes a mix of dry eye syndrome treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe dry eye syndrome treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe dry eye syndrome treatment market size, by country, 2018-2030 (US$M)
Europe Dry Eye Syndrome Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
